• Accueil >
  • Publications >
  • Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2

Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2

1 janv. 2015European Journal of Cancer

DOI : 10.1016/j.ejca.2014.10.009

Auteurs

Stéphane Oudard, Stéphane Culine, Yann Vano, François Goldwasser, Christine Théodore, Thierry Nguyen, Eric Voog, Eugeniu Banu, Annick Vieillefond, Franck Priou, Gaël Deplanque, Gwenaëlle Gravis, Alain Ravaud, Jean Michel Vannetzel, Jean-Pascal Machiels, Xavier Muracciole, Marie-France Pichon, Jacques-Olivier Bay, Reza Elaidi, Corine Teghom, François Radvanyi, Philippe Beuzeboc

Membres

FRANCOIS RADVANYI

Directeur de recherche